Houghton Mifflin Harcourt Company
HMHC
HMHC was delisted on the 6th of April, 2022.
0 hedge funds and large institutions have $0 invested in Houghton Mifflin Harcourt Company in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $2K → $0 (-$2K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Repertoire Partners
New York
|
-$2K |
HMHC Hedge Fund Activity: Q3 2022 in Review
0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Houghton Mifflin Harcourt Company (HMHC) for Q3 2022, worth a combined $0 — down 100% from $2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HMHC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Repertoire Partners, exiting entirely with an estimated $2K sold.
- 0 institutional investors held Houghton Mifflin Harcourt Company (HMHC) as of Q3 2022, down from 1 in Q2 2022.
- Funds reported $0 of Houghton Mifflin Harcourt Company stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new Houghton Mifflin Harcourt Company positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest Houghton Mifflin Harcourt Company seller in Q3 2022 was Repertoire Partners, an estimated $2K sold.
Based on aggregated 13F filings for Q3 2022.